Conspicuous facial pores are one type of serious esthetic defects for many women. We previously reported that the severity of impairment of skin architecture around facial pores correlates well with the appearance of facial pores in several ethnic groups. In our last report, we showed that serum levels of insulin-like growth factor-1 (IGF-1) correlate well with facial pore size and with the severity of impairment of epidermal architecture around facial pores. However, our results could not fully explain the implication between facial pores and IGF signaling. In this study, we conducted a histological analysis of facial skin to determine whether potential changes in IGF-1 availability occur in the skin with or without conspicuous pores. Immunohistochemical observations showed that expression of insulin-like growth factor binding protein-3 (IGFBP-3) is limited to the suprapapillary epidermis around facial pores and to basal cells of rete pegs without tips in epidermis with conspicuous pores. In contrast, in basal cells of skin without conspicuous pores, IGFBP-3 expression is very low. Ki-67 and IGF-1 receptor-positive cells are abundant in basal cells in the tips of the rete pegs in skin with typical epidermal architecture around facial pores. No obvious differences were observed in the expression of filaggrin, involucrin, K1, K6 or K17 in skin with or without conspicuous pores. However, increased expression of K16 was observed in skin with conspicuous pores suggesting hyperproliferation. These results suggest that the IGF-1/IGFBP-3 signaling pathway is involved in the formation of conspicuous facial pores due to the epidermal architecture around facial pores.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Batch JA, Mercuri FA, Edmondson SR, Werther GA (1994) Localization of messenger ribonucleic acid for insulin-like growth factor binding proteins in human skin by in situ hybridization. J Clin Endocrinol Metab 79:1444–1449
Dennis DK (1974) Ultrastructural observations in acne vulgaris: the normal sebaceous follicle and acne lesions. J Invest Dermatol 62:288–307
Hillebrand GG, Levine MJ, Miyamoto K (2001) The age-dependent changes in skin condition in African Americans, Asian Indians, Caucasians, East Asians and Latinos. IFSCC Mag 4:259–266
Hughes BR, Morris C, Cunliffe WJ, Leigh IM (1996) Keratin expression in pilosebaceous epithelia in truncal skin of acne patients. Br J Dermatol 134:247–256
Iida T, Katsuta Y, Inomata S (2004) Effect of sebum component on skin condition around facial pore and improvement of conspicuous pores by polyxyethylene/polyoxypropylene dimethyl ether. Fragrance J 32:41–47
Jones JI, Clemmons DR (1995) Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3–34
Kligman AM (1974) An overview of acne. J Invest Dermatol 62:268–287
Liu JP, Baker J, Archibald S (1993) Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59–72
Nishijima T, Ohsu H, Kitahara T, Takema Y (2001) Regional difference in morphological changes in facial skin surface with aging. J Soc Cosmet Chem Jpn 35:141–148
Pierard GE, Pierard-Franchimont C, Marks R, Paye M, Rogiers V (2000) EEMCO guidance for the in vivo assessment of skin greasiness. Skin Pharmacol Appl Skin Physiol 13:372–389
Ristow HJ (1993) Effect of insulin-like growth factor-I/somatomedin C on thymidine incorporation in cultured psoriatic keratinocytes after growth arrest in growth factor-free medium. Growth Regul 3:129–137
Roh M, Han M, Kim D, Chung K (2006) Sebum output as a factor contributing to the size of facial pores. Br J Dermatol 155:890–894
Smith TM, Cong Z, Gilliland KL (2006) Insulin-like growth factor-1 induces lipid production in human SEB-1 sebocytes via sterol response element-binding protein-1. J Invest Dermatol 126:1226–1232
Smith TM, Gilliland K, Clawson GA, Thiboutot D (2008) IGF-1 induces SREBP-1 expression and lipogenesis in SEB-1 sebocytes via activation of the phosphoinositide 3-kinase/Akt pathway. J Invest Dermatol 128:1286–1293
Sugata K, Nishijima T, Kitahara T, Takema T (2008) Confocal laser microscopic imaging of conspicuous facial pores in vivo: relation between the appearance and the internal structure of skin. Skin Res Technol 14:208–212
Sugiyama-Nakagiri Y, Sugata K, Iwamura M, Ohuchi A, Kitahara T (2008) Age-related changes in the epidermal architecture around facial pores. J Dermatol Sci 50:151–154
Sugiyama-Nakagiri Y, Sugata K, Hachiya A, Osamu O, Ohuchi A, Kitahara T (2009) Ethnic differences in the structural properties of facial skin. J Dermatol Sci 53:135–139
Sugiyama-Nakagiri Y, Naoe A, Ohuchi A, Kitahara T (2010) Serum levels of IGF-1 are related to human skin characteristics including the conspicuousness of facial pores. Int J Cosmet Sci (in press)
Takahashi M, Watanabe H, Kumagai H (1989) Physiological and morphological changes in facial skin with aging (II)—a study on racial differences. J Soc Cosmet Chem Jpn 23:22–30
Takahashi K, Folmer J, Coulombe PA (1994) Increased expression of keratin 16 caused anomalies in cytoarchitecture and keratinization in transgenic mouse skin. J Cell Biol 127:505–520
Tsai CH, Yang SF, Chen YJ (2005) The upregulation of insulin-like growth factor-1 in oral submucous fibrosis. Oral Oncol 41:940–946
Vora S, Ovhal A, Jerajani H, Nair N, Chakraborty A (2008) Correlation of facial sebum to serum insulin-like growth factor-1 in patients with acne. Br J Dermatol 159:990–991
Wraight C, Murashita M, Russo V, Werther G (1994) A keratinocyte cell line synthesizes a predominant insulin-like growth factor-binding protein (IGFBP-3) that modulates insulin-like growth factor-I action. J Invest Dermatol 103:627–631
Wraight CJ, Edmondson SR, Fortune DW, Varigos G, Werther GA (1997) Expression of insulin-like growth factor binding protein-3 (IGFBP-3) in the psoriatic lesion. J Invest Dermatol 108:452–456
Wraight CJ, White PJ, Mckean SC, Fogarty RD, Venables DJ, Liepe IJ, Edmondson SR, Werther GA (2000) Reversal of epidermal hyperproliferation in psoriasis by insulin-like growth factor I receptor antisense oligonucleotides. Nat Biotechnol 18:521–526
Conflict of interest statement
None of the authors has a conflict of interest including any financial, personal or other relationships with other people or organizations that could inappropriately influence this work.
About this article
Cite this article
Sugiyama-Nakagiri, Y., Ohuchi, A., Hachiya, A. et al. Involvement of IGF-1/IGFBP-3 signaling on the conspicuousness of facial pores. Arch Dermatol Res 302, 661–667 (2010). https://doi.org/10.1007/s00403-010-1062-3
- Conspicuous pore
- Epidermal architecture